Vanguard Group Inc T2 Biosystems, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.15 - $0.54 $609,420 - $2.19 Million	4,062,800 Added 80.84%	9,088,832 $1.47 Million
Q1 2022 May 13, 2022	SELL	$0.36 - $0.57 $594,912 - $941,945	-1,652,536 Reduced 24.74%	5,026,032 $2.63 Million
Q4 2021 Feb 14, 2022	BUY	$0.46 - $0.94 $68,609 - $140,201	149,151 Added 2.28%	6,678,568 $3.45 Million
Q3 2021 Nov 12, 2021	BUY	$0.86 - $1.21 $10,442 - $14,693	12,143 Added 0.19%	6,529,417 $5.98 Million
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.69 $6.78 Million - $11 Million	6,517,274 New	6,517,274 $7.76 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.